Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- EUROPEAN JOURNAL OF CANCER49(2) · pp.403 · 2013
- 피인용
- Web of Science 25
- JCR IF
- JCR 2012 5.061
- ISSN
- 0959-8049
저자
- Kim, Kyung Im제1저자서울대학교, Coll Pharm, KO
- Huh, Ik-Soo서울대학교, Dept Stat, KO
- Kim, In-Wha서울대학교, Pharmaceut Sci Res Inst, KO
- Park, Taesung서울대학교, Dept Stat, KO
- Ahn, Kwang-Sung서울대학교, Clin Res Inst, KO
- Yoon, Sung-Soo서울대학교, Canc Res Inst, KO
- 윤정현부산대학교, 약학대학, 약학부, 약학전공, KO
- Oh, Jung Mi교신저자서울대학교, Pharmaceut Sci Res Inst, KO
초록
Cytarabine arabinoside (ara-C) is the key agent for treating acute myeloid leukaemia (AML). Here, we genotyped 139 single nucleotide polymorphisms (SNPs) within the araC transport and metabolic pathway using the Illumina Golden Gate Assay in 97 patients with previously non-treated de novo AML other than M3. DCK rs4694362 (CC genotype) was a significant poor prognostic factor for overall survival (OS) (hazard ratio [HR], 33.202 [95% confidence interval (CI), 4.937-223.273], P < 0.0001, P-Bonferroni = 0.017). SLC29A1 rs3734703 (AA or AC genotype) in combination with TYMS rs2612100 (AA genotype) was significantly associated with shorter relapse free survival (RFS) (HR, 17.630 [95% CI, 4.829-64.369], P < 0.0001, P-Bonferroni = 0.021). These SNPs showed moderate or large inter-ethnic divergence in allele frequencies from African or Caucasian populations. The results of our study suggest that a single SNP and SNP-SNP interactions may help to predict the drug response and provide a guide in developing individualised chemotherapy for AML patients receiving ara-C based chemotherapy. (C) 2012 Elsevier Ltd. All rights reserved.
키워드
Acute myeloid leukaemiaSingle nucleotide polymorphismSNP-SNP interactionCytarabineResponseEthnicitySINGLE-NUCLEOTIDE POLYMORPHISMARA-C SENSITIVITYDEOXYCYTIDINE KINASECYTOSINE-ARABINOSIDE1-BETA-D-ARABINOFURANOSYLCYTOSINETHYMIDINEEXPRESSIONSURVIVALTHERAPYCELLS
식별자
- WoS UID
- 000313193000016



로그인
연구물 목록으로